Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15236879.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A large, rapidly progressing, unresectable undifferentiated sinonasal head and neck carcinoma regressed rapidly following single fraction boron neutron capture therapy (BNCT). The main toxicity consisted of mucositis lasting for a few days. The quality of life improved and was excellent until tumour recurrence 6 months after the date of BNCT.
Medical subject headings
- Boron Neutron Capture Therapy
- Carcinoma
- Paranasal Sinus Neoplasms